Señales en vivo de ICO.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 06:54):

Stats
Volumen de hoy	40 641.00
Volumen promedio	55 023.00
Capitalización de mercado	95.22M
EPS	SEK0 ( 2024-04-25 )
Próxima fecha de ganancias	( SEK0 ) 2024-07-12
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.480
ATR14	SEK0.107 (1.32%)

Iconovo AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Iconovo AB (publ) Finanzas

Annual	2023
Ingresos:	SEK7.08M
Beneficio Bruto:	SEK-53.81M (-760.22 %)
EPS:	SEK-4.39

FY	2023
Ingresos:	SEK7.08M
Beneficio Bruto:	SEK-53.81M (-760.22 %)
EPS:	SEK-4.39

FY	2022
Ingresos:	SEK17.12M
Beneficio Bruto:	SEK17.24M (100.75 %)
EPS:	SEK-5.69

FY	2021
Ingresos:	SEK15.41M
Beneficio Bruto:	SEK21.31M (138.27 %)
EPS:	SEK-0.832

Financial Reports:

No articles found.

Iconovo AB (publ)

Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius AB (publ) to develop inhalation product to treat COPD. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.